Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHRISTOPHER CASE

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1871552794
CMS profile
129686
Location
JEFFERSON CITY, MO

General Payments · PY2018–2024

$143,985.19

  • Reported across 443 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$10,589.10

48 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $10,306.04 25
Corcept Therapeutics $155.73 16
Amgen Inc. $36.39 2
NOVARTIS PHARMACEUTICALS CORPORATION $22.40 1
Averitas Pharma Inc. $21.31 1
TOLMAR, INC. $16.97 1
DEXCOM, INC. $15.38 1
MannKind Corporation $14.88 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $31,506.92 118
PY2019 $26,873.69 83
PY2020 $12,278.89 42
PY2021 $22,452.12 66
PY2022 $31,629.13 72
PY2023 $8,655.34 14
PY2024 $10,589.10 48

Payment records · PY2024 (48)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $18.37 04/16/2024 Food and Beverage Undisputed 01/23/2026 1111543945 CMS
Amgen Inc. $18.02 10/16/2024 Food and Beverage Undisputed 01/23/2026 1111543943 CMS
Averitas Pharma Inc. $21.31 07/17/2024 Food and Beverage Undisputed 01/23/2026 1133420594 CMS
Corcept Therapeutics $6.37 01/05/2024 Food and Beverage Undisputed 01/23/2026 1117771619 CMS
Corcept Therapeutics $14.81 01/25/2024 Food and Beverage Undisputed 01/23/2026 1117771621 CMS
Corcept Therapeutics $8.50 02/21/2024 Food and Beverage Undisputed 01/23/2026 1117771625 CMS
Corcept Therapeutics $12.35 03/18/2024 Food and Beverage Undisputed 01/23/2026 1117771635 CMS
Corcept Therapeutics $11.67 04/17/2024 Food and Beverage Undisputed 01/23/2026 1117771643 CMS
Corcept Therapeutics $12.60 05/15/2024 Food and Beverage Undisputed 01/23/2026 1117771645 CMS
Corcept Therapeutics $9.89 06/03/2024 Food and Beverage Undisputed 01/23/2026 1117771651 CMS
Corcept Therapeutics $7.55 06/24/2024 Food and Beverage Undisputed 01/23/2026 1117771661 CMS
Corcept Therapeutics $13.04 07/17/2024 Food and Beverage Undisputed 01/23/2026 1117771663 CMS
Corcept Therapeutics $3.64 08/12/2024 Food and Beverage Undisputed 01/23/2026 1117771669 CMS
Corcept Therapeutics $4.16 08/27/2024 Food and Beverage Undisputed 01/23/2026 1117771671 CMS
Corcept Therapeutics $4.86 09/23/2024 Food and Beverage Undisputed 01/23/2026 1117771687 CMS
Corcept Therapeutics $11.29 09/23/2024 Education Undisputed 01/23/2026 1117771779 CMS
Corcept Therapeutics $5.83 10/15/2024 Food and Beverage Undisputed 01/23/2026 1117771697 CMS
Corcept Therapeutics $15.83 11/26/2024 Food and Beverage Undisputed 01/23/2026 1117771763 CMS
Corcept Therapeutics $13.34 12/16/2024 Food and Beverage Undisputed 01/23/2026 1117771777 CMS
Dexcom, Inc. $15.38 10/21/2024 Food and Beverage Undisputed 01/23/2026 1153292173 CMS
Mannkind Corporation $14.88 03/18/2024 Food and Beverage Undisputed 01/23/2026 1145840195 CMS
Novartis Pharmaceuticals Corporation $22.40 03/13/2024 Food and Beverage Undisputed 01/23/2026 1086762419 CMS
Novo Nordisk Inc $7.53 01/25/2024 Food and Beverage Undisputed 01/23/2026 1097223189 CMS
Novo Nordisk Inc $938.00 03/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1097621524 CMS
Novo Nordisk Inc $4.35 03/26/2024 Food and Beverage Undisputed 01/23/2026 1096702717 CMS
Novo Nordisk Inc $1,595.00 04/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1096626776 CMS
Novo Nordisk Inc $938.00 04/10/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1097587109 CMS
Novo Nordisk Inc $116.12 04/11/2024 Food and Beverage Undisputed 01/23/2026 1096628121 CMS
Novo Nordisk Inc $154.10 04/11/2024 Travel and Lodging Undisputed 01/23/2026 1096700437 CMS
Novo Nordisk Inc $3,093.75 04/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1097124709 CMS
Novo Nordisk Inc $750.00 04/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1096952909 CMS
Novo Nordisk Inc $938.00 04/16/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1097563005 CMS
Novo Nordisk Inc $750.00 04/25/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1096663287 CMS
Novo Nordisk Inc $938.00 04/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1097807827 CMS
Novo Nordisk Inc $5.82 05/15/2024 Food and Beverage Undisputed 01/23/2026 1097147593 CMS
Novo Nordisk Inc $8.63 06/07/2024 Food and Beverage Undisputed 01/23/2026 1097573550 CMS
Novo Nordisk Inc $7.30 06/18/2024 Food and Beverage Undisputed 01/23/2026 1096885438 CMS
Novo Nordisk Inc $0.98 08/27/2024 Food and Beverage Undisputed 01/23/2026 1096574472 CMS
Novo Nordisk Inc $6.62 08/27/2024 Food and Beverage Undisputed 01/23/2026 1096944573 CMS
Novo Nordisk Inc $6.52 10/01/2024 Food and Beverage Undisputed 01/23/2026 1097713818 CMS
Novo Nordisk Inc $5.72 10/08/2024 Food and Beverage Undisputed 01/23/2026 1097715354 CMS
Novo Nordisk Inc $6.56 10/29/2024 Food and Beverage Undisputed 01/23/2026 1096637411 CMS
Novo Nordisk Inc $5.69 11/05/2024 Food and Beverage Undisputed 01/23/2026 1096713363 CMS
Novo Nordisk Inc $8.28 11/19/2024 Food and Beverage Undisputed 01/23/2026 1097406165 CMS
Novo Nordisk Inc $5.03 12/10/2024 Food and Beverage Undisputed 01/23/2026 1097229409 CMS
Novo Nordisk Inc $7.60 12/10/2024 Food and Beverage Undisputed 01/23/2026 1097486982 CMS
Novo Nordisk Inc $8.44 12/17/2024 Food and Beverage Undisputed 01/23/2026 1097086022 CMS
Tolmar, Inc. $16.97 11/12/2024 Food and Beverage Undisputed 01/23/2026 1138715508 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.